Home Infusion Therapy Highlighted at NHIA 2025
The conference brings together 1,600 home and alternate site infusion professionals for four days of networking, education & exhibits

ALEXANDRIA, Virginia—The 2025 National Home Infusion Association Annual Conference (NHIA 2025) concluded earlier this month. The conference brings together 1,600 home and alternate site infusion professionals for four days of networking, education and exhibits. This year's event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.

Melinta Therapeutics Joins NHIA Infusion Advisory Council
Biopharmaceutical company Melinta Therapeutics added to the National Home Infusion Association’s Future of Infusion Advisory Council

ALEXANDRIA, Virginia & PARSIPPANY, New Jersey—The National Home Infusion Association (NHIA) and Melinta Therapeutics LLC, a biopharmaceutical company that provides therapy for individuals with acute and life-threatening illnesses, announced that Melinta has been added to NHIA’s Future of Infusion Advisory Council (FIAC).

Patient, Stakeholder Group Urges Congress to Address Medicare Home Infusion Benefit
More than 35 stakeholder groups from across the health care continuum are urging Congress to pass legislation to address the failed Medicare benefit

ALEXANDRIA, Virginia—The National Home Infusion Association (NHIA), a home infusion therapy community and manufacturer, reported that a collective of more than 35 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services.

NHIA Releases Product Shortages Guidance
The National Home Infusion Association presented guidelines on managing product shortages during disruptions in manufacturing after Hurricane Helene’s damages

ALEXANDRIA, Virginia—In response to the report on the operational disruption at Baxter’s North Cove, North Carolina, facility due to Hurricane Helene, the National Home Infusion Association (NHIA) released a guidance list that aims to provide health care organizations with a structured approach for managing product shortages, particularly of diluents, parenteral nutrition (PN) products and small and large volume parenteral solutions.


NHIA Comments on CMS Home Health Proposed Rule
The National Home Infusion Association made comments on the proposed rule for home health, home infusion therapy & intravenous immune globulin services

ALEXANDRIA, Virginia—The National Home Infusion Association (NHIA), a trade association representing infusion companies and providers, commented on a proposed rule on Medicare home health (HH) programs from the Center for Medicare and Medicaid Services (CMS). 

NHIA Releases List of Home Infusion Medications
The list of medications reflects current U.S. prescribing practices

ALEXANDRIA, Virginia—The National Home Infusion Association (NHIA) has developed a list of medications to serve as a reference when making site of care decisions for patients requiring intravenous (IV) or subcutaneous (SC) infusions. The list of medications reflects current U.S. prescribing practices and was compiled from home infusion providers' medication dispensing reports and reviewed by NHIA’s Quality and Standards Committee. 

The Intersection of Homecare and Infusion is Growing

It’s no secret that our health care system is increasingly shifting the site of care to the patient’s home. Infusion therapy is the among the specialized services that can be delivered in the home, safely and effectively—but it requires a nurse’s care. For decades, home infusion pharmacy and home care nursing have been interconnected. Today, that intersection is growing and the need for highly skilled home infusion nurses has never been stronger.

NHIA Names New President and CEO

ALEXANDRIA, Va. (November 29, 2018)—The National Home Infusion Association (NHIA), representing providers and suppliers of home and specialty infusion therapy, announced that its board of directors has appointed Connie Sullivan, BSPharm, president and chief executive officer, effective December 1, 2018. Sullivan will be the first pharmacist to hold the position of CEO since NHIA’s inception in 1991.

Medical company declines to answer Senate questions on Medicare billing

WASHINGTON, D.C., May 23, 2013—As reported by Lindsay Wise, McClatchy Washington Bureau, in the Kansas City Star, the president and chief executive officer of a medical equipment company invoked the Fifth Amendment at Senate hearing Wednesday, declining to answer questions about aggressive marketing tactics used to sell scooters, sleep apnea machines and other home medical supplies to Medicare recipients who may not need or want them. Jon Letko of U.S.